肾脏病与透析肾移植杂志 ›› 2014, Vol. 23 ›› Issue (2): 176-178.
• 论文 • 上一篇 下一篇
出版日期:
发布日期:
Online:
Published:
摘要:
摘 要:泛素-核糖体融合蛋白52(UbA52)是目前发现的、对早期糖尿病肾病(DN)有重要诊断价值的生物标志物。UbA52是由一种泛素编码基因UbA52翻译表达的,其可能通过参与氧化应激及泛素蛋白酶体途径(UPP),从而参与早期DN的发病。其表达水平与体内血糖水平呈正相关,并只局限表达于肾小管;而尿中UbA52的水平直接与DN的关系密切。目前已经被认为是DN早期诊断的标志物,并且基于尿蛋白组学技术的这一领域正在飞速发展。
Abstract:
Abstract: Ubiquitin-52 amino acid fusion protein (UbA52) is found in the early diagnosis of diabetic nephropathy has important biological indicators. UbA52 is translated and expressed by UbA52 gene which participate in oxidative stress and the ubiquitin-proteasome pathway (UPP). So UbA52 participate in the pathogenesis of diabetic nephropathy. With experiments show that UbA52 gene expression and the glucose levels in vivo were positively correlated. The UbA52 confined to the renal tubules. The level of urine UbA52 directly and closely related to diabetic nephropathy. UbA52 can be used as an index of early diagnosis of diabetic nephropathy And this area based on the technology of urinary proteomics is rapid development .
Key words: Diabetic Nephropathy, Ubiquitin-52 amino acid fusion protein, Diagnosis
杨旭升| 张蕾. 泛素?核糖体融合蛋白52——糖尿病肾病的早期生物标志物[J]. 肾脏病与透析肾移植杂志, 2014, 23(2): 176-178.
YANG Xusheng| ZHANG Lei. null[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2014, 23(2): 176-178.
0 / / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: http://www.njcndt.com/CN/
http://www.njcndt.com/CN/Y2014/V23/I2/176